Olstein Capital Management’s Integra LifeSciences IART Stock Holding History

Olstein Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-123,000	Closed	-$1.53M	–	103
2025 Q4	$1.53M	Sell	123,000 -16,000	-12%	-$213K	0.31%	83
2025 Q3	$1.99M	Buy	139,000 +4,000	+3%	+$54.8K	0.38%	85
2025 Q2	$1.66M	Buy	135,000 +37,000	+38%	+$537K	0.31%	85
2025 Q1	$2.15M	Sell	98,000 -35,000	-26%	-$823K	0.4%	79
2024 Q4	$3.02M	Sell	133,000 -22,000	-14%	-$480K	0.53%	74
2024 Q3	$2.82M	Buy	155,000 +42,000	+37%	+$974K	0.48%	75
2024 Q2	$3.29M	Buy	113,000 +13,000	+13%	+$386K	0.59%	68
2024 Q1	$3.54M	Buy	100,000 +26,000	+35%	+$1.04M	0.58%	69
2023 Q4	$3.22M	Buy	74,000 +3,000	+4%	+$118K	0.54%	72
2023 Q3	$2.71M	Buy	71,000 +2,000	+3%	+$84.1K	0.46%	83
2023 Q2	$2.84M	Buy	69,000 +24,000	+53%	+$1.16M	0.46%	87
2023 Q1	$2.58M	Sell	45,000 -1,000	-2%	-$56.3K	0.4%	90
2022 Q4	$2.58M	Hold	46,000	–	–	0.4%	90
2022 Q3	$1.95M	Buy	46,000 +1,000	+2%	+$51.2K	0.33%	91
2022 Q2	$2.43M	Buy	45,000 +3,000	+7%	+$180K	0.36%	91
2022 Q1	$2.7M	Sell	42,000 -3,000	-7%	-$198K	0.34%	96
2021 Q4	$3.02M	Buy	45,000 +4,000	+10%	+$271K	0.36%	92
2021 Q3	$2.81M	Sell	41,000 -5,000	-11%	-$353K	0.34%	95
2021 Q2	$3.14M	Hold	46,000	–	–	0.4%	93
2021 Q1	$3.18M	Hold	46,000	–	–	0.44%	84
2020 Q4	$2.99M	Buy	46,000 +3,000	+7%	+$161K	0.48%	77
2020 Q3	$2.03M	Buy	43,000 +7,000	+19%	+$333K	0.37%	86
2020 Q2	$1.69M	Buy	36,000 +4,290	+14%	+$211K	0.32%	91
2020 Q1	$1.42M	Buy	31,710 +10,710	+51%	+$562K	0.31%	90
2019 Q4	$1.22M	Buy	21,000 +12,000	+133%	+$714K	0.19%	103
2019 Q3	$541K	Buy	9,000 +1,000	+13%	+$59.6K	0.08%	112
2019 Q2	$447K	Buy	+8,000	New	+$412K	0.07%	111
2015 Q3	–	Sell	-141,895	Closed	-$3.91M	–	112
2015 Q2	$3.91M	Sell	141,895 -4,893	-3%	-$130K	0.41%	105
2015 Q1	$3.7M	Buy	146,788 +7,339	+5%	+$173K	0.4%	105
2014 Q4	$3.09M	Buy	139,449 +4,893	+4%	+$99.2K	0.38%	101
2014 Q3	$2.73M	Hold	134,556	–	–	0.36%	108
2014 Q2	$2.59M	Buy	134,556 +14,679	+12%	+$274K	0.35%	106
2014 Q1	$2.25M	Buy	+119,877	New	+$2.31M	0.31%	107

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Olstein Capital Management's IART Position: Q1 2026 in Review

Olstein Capital Management sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 123,000 shares — an estimated $1.53M sold.

Olstein Capital Management first reported a position in IART in Q1 2014 and held it in 33 quarters. The position peaked at $3.91M in Q2 2015. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Olstein Capital Management reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
Olstein Capital Management sold 123,000 Integra LifeSciences shares in Q1 2026, an estimated $1.53M.
Olstein Capital Management first reported a position in Integra LifeSciences in Q1 2014 and held it in 33 quarters.
Olstein Capital Management's Integra LifeSciences position peaked at $3.91M in Q2 2015.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Olstein Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.